Related references
Note: Only part of the references are listed.Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez et al.
CANCER DISCOVERY (2020)
First-in-human phase 1 study of ABBV-085, an antibody-drug conjugate (ADC) targeting LRRC15, in sarcomas and other advanced solid tumors.
George D. Demetri et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Jo Lynne Rokita et al.
CELL REPORTS (2019)
Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
Meghdad Abdollahpour-Alitappeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
James W. Purcell et al.
CANCER RESEARCH (2018)
LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation
Yuejun Wang et al.
STEM CELL RESEARCH & THERAPY (2018)
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance
Naoki Takegawa et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
ABBV-085 is a novel antibody drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment
J. Purcell et al.
EUROPEAN JOURNAL OF CANCER (2016)
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Michal Kovac et al.
NATURE COMMUNICATIONS (2015)
Preclinical childhood sarcoma models: drug efficacy biomarker identification and validation
Brian Geier et al.
FRONTIERS IN ONCOLOGY (2015)
Genomic Heterogeneity of Osteosarcoma - Shift from Single Candidates to Functional Modules
Kathrin Poos et al.
PLOS ONE (2015)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Molecular characterization of the pediatric preclinical testing panel
Geoffrey Neale et al.
CLINICAL CANCER RESEARCH (2008)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
